| Literature DB >> 34738469 |
Ayokunle A Olagoke1,2, Leslie R Carnahan1,3, Olakanmi Olagoke4, Yamilé Molina1,5.
Abstract
PURPOSE: This study aimed at targeting shared factors that influence the prevention of multiple diseases, which can help address various health problems simultaneously. We identified correlates of human papillomavirus (HPV) vaccination that overlap with COVID-19 vaccination.Entities:
Keywords: COVID-19 vaccine; HPV vaccine; disease management; health communications; human papillomavirus; immunizations; resource consolidation; vaccine intention
Mesh:
Substances:
Year: 2021 PMID: 34738469 PMCID: PMC8851043 DOI: 10.1177/08901171211053933
Source DB: PubMed Journal: Am J Health Promot ISSN: 0890-1171
Participants’ Characteristics (N = 342).
| Participants’ Psychological and Outcome Characteristics | M (SD) |
|---|---|
| Perceived vulnerability to HPV | 3.71 (1.13) |
| Perceived severity of HPV | 4.32 (.82) |
| Perceived response efficacy of HPV vaccine | 3.61 (1.12) |
| COVID-19 vaccination intention for self | 3.19 (1.57) |
| COVID-19 vaccination intention for child | 3.09 (1.55) |
| HPV vaccination intention for child | 3.02 (1.32) |
| Participants' sociodemographic and socioeconomic characteristics | |
| Parents’ age: mean = 41.33 years (standard deviation = 5.47). Child’s age: mean = 14.08 years (standard deviation = 2.05) | |
| Parent’s sex: Female (46%), males (54%) | |
| Child’s sex: Female (34%), males (66%) | |
| Race: White (87%), non-White (13%) | |
| Marital status: Married (89%), non-married (11%) | |
| Highest education: Less than a college degree (25%), college or more (75%) | |
| Household income: Less than $75,000 (31%), over $75,000 (69%) | |
| Employment status: Employed (83%), unemployed/retired/disabled/others (17%) | |
Multivariate Linear Regression on Vaccination Intentions.
| COVID-19 Vaccination Intention for Self | |
|---|---|
| Psychological Factors | β (95% CI) |
| Perceived vulnerability of child to HPV | .37 (.25–.48)a |
| Perceived severity of HPV | .21 (.05–.38)b |
| Perceived response efficacy of HPV vaccine | .46 (.33–.59)a |
| COVID-19 vaccination intention for child | |
| Perceived vulnerability of child to HPV | .32 (.21–.44)a |
| Perceived severity of HPV | .16 (−.01–.32) |
| Perceived response efficacy of HPV vaccine | .41 (.28–.53)a |
| HPV vaccination intention for child | |
| Perceived vulnerability of child to HPV | .38 (.27–.49)a |
| Perceived severity of HPV | .33 (.17–.49)a |
| Perceived response efficacy of HPV vaccine | .75 (.64–.85)a |
aP < .0001, bP < .01.